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Summary
Background Th2 cells have long been considered responsible for the switching of B cells
to production of IgE during cognate interaction, primarily due to their expression of
CD40L and secretion of IL-4. This concept has been challenged by the more recent defini-
tion of follicular helper T cells (Tfh) as the key T cell subset in B cell isotype switching,
due to their physical location at the boundary of T cell:B cell areas in lymphoid follicles
and ability to express IL-4 and CD40L.
Objective To determine whether Tfh cells are responsible for IgE responses to Der p 1
allergen after house dust mite (HDM)-induced allergic sensitization.
Methods Mice deficient in Tfh cells were sensitized to HDM and Der p 1-specific IgE mea-
sured by ELISA.
Results Mice with a mutation in T cell-expressed IL-6R were unable to expand Tfh popu-
lations after HDM sensitization, and their anti-Der p 1 IgE, IgG1 and total IgE responses
were reduced by 80–90% compared with wild-type mice. These animals displayed
unaltered lung Th2 and eosinophilic responses after intranasal HDM challenge and normal
IL-4 production, but B cell infiltration of the airways was abrogated.
Conclusions and Clinical Relevance Our data indicate that Tfh cells are largely responsible
for switching B cells to IgE synthesis, most likely via an IgG1+ intermediate. However,
Th2 cells are the major source of IL-4 during HDM sensitization and this might contribute
to IgE synthesis at a stage distal to Tfh-mediated isotype switching. The IL-6/follicular
helper T cell pathway is a potential therapeutic target in allergic disease.
Keywords IgE, follicular helper T cell, Th2 cell, Der p 1, house dust mite
Submitted 27 August 2015; revised 18 February 2016; accepted 28 April 2016
Introduction
Mature B lymphocytes are not capable of producing IgE
antibodies until a process of isotype switching, trig-
gered by interaction with T cells recognizing the same
allergen, has occurred. Th2 cells have long been consid-
ered the T cell subset responsible for the switching of B
cells to IgE synthesis from IgM or IgG isotypes [1].
However, this paradigm has been challenged by the
more recent characterization of follicular helper T cells
(Tfh) as the key T cell involved in isotype switching,
consistent with their presence in germinal centres of
lymphoid tissues [2]. By contrast, Th2 cells may prefer-
entially migrate to mucosal tissues exposed to allergens,
driving allergic inflammation [3]. Tfh are CD4+ T cells
expressing CXCR5, the receptor for CXCL13 chemokine,
which mediates migration towards the boundary of T
cell and B cell areas of lymphoid follicles where isotype
switching occurs [4]. Furthermore, Tfh express CD40L
and secrete IL-4 [2], the key factors responsible for IgE
switching. They also produce IL-21, a cytokine that
stimulates B cell growth but has been reported to sup-
press IgE synthesis [5]. Mice with reduced numbers of
Tfh are deficient in IgG antibody responses [6], but the
role of Tfh in IgE responses to common aeroallergens
has not been definitively demonstrated. Indeed, it has
been suggested that switching to IgE can occur in
poorly organized germinal centres or in mucosal tissues
by a direct IgM to IgE switch [7–9]. IgE switching in
germinal centres is believed to occur via an IgG4+
intermediate stage in humans or an IgG1+ B cell in
mice [10, 11].
To address the role of Tfh cells in IgE responses to
house dust mite (HDM) allergen, we used mice genetically
modified to lack IL-6 receptor signalling specifically
within the T cell compartment. IL-6 is the key cytokine
driving Tfh development via STAT3 signalling and
expression of the bcl-6 transcription factor, in combina-
tion with IL-21, which is produced by Tfh cells [12–14].
This contrasts with the Th2 developmental pathway
involving IL-4, STAT6 and GATA-3. We sensitized these
animals with HDM and elicited allergic airway inflamma-
tion and anti-Der p 1-specific IgE antibody responses.
Our data reveal a key role for Tfh in IgE switching of B
cells responding to HDM.
Methods
Mice
Wild-type C57BL/6 mice were purchased from Harlan
UK (Bicester, UK). CD4Crexgp130/ mice [15], which
lack the IL-6R signalling component specifically on T
cells, were on a C57BL/6 background and bred in our
specific-pathogen-free facility. Male and female animals
were used. Experimental groups were matched for age
and sex and co-housed for several weeks before use at
8–12 weeks of age. Experimental procedures were per-
formed under UK Home Office authorization with
approval from our institutional committee and in accor-
dance with EU directives.
House dust mite sensitization and challenge
Each mouse was immunized i.p. with 25 lg HDM extract,
prepared by sonication of whole Dermatophagoides
pteronyssinus (Allergon AB, Angelholm, Sweden) in PBS
and adsorbed to 200 lL alum gel (Alu-Gel-S, Serva, Hei-
delberg, Germany), on days 0 and 14. On days
21,24,25,26 and 27, mice were challenged with 25 lg
HDM in 50 lL PBS intranasally. Animals were killed
24 h after the final challenge, and bronchoalveolar
lavage (BAL) was performed with 1 mL PBS. Left lungs
were weighed and digested with collagenase (250 lg/mL,
Sigma) for 45 min to extract cells for flow cytometry.
Right lungs were prepared for histology as described
[16]. Blood was collected from the tail on day 14 and by
cardiac puncture on day 28. Serum was collected and
stored at 20°C, and anti-coagulated blood (sodium
citrate) was stained directly with mAbs. Respiratory (me-
diastinal) lymph nodes were excised for cell culture.
T cell culture
Lymph node cell suspensions were cultured at 5 9 106/
mL in XVIVO-15 serum-free medium (Lonza, Blackley,
UK), 37°C 5% CO2. HDM (10 lg/mL) was added
alongside diluent controls. After 4 days, cell super-
natants were collected.
Flow cytometry
Staining was performed with 50 lL blood or BAL/lung
cells and 0.1 lg antibodies in 100 lL PBS+1% FBS.
Antibodies used were as follows: anti-CXCR5-APC
(SPRCL5), anti-PD-1-PerCPeFluor710 (J43), anti-IL-33R
(ST2)-PerCPeFluor710 (RMST2-2), anti-IFN-c-PE/Cy7
(XMG1.2), anti-IL-4-PE (11B11), anti-IL-17A-eFluor660
(eBio17B7), anti-CD4-FITC (RM4-5), all from eBio-
science (Hatfield, UK) and anti-CD8ß-APC (53-5.8, Bio-
Legend, London, UK). Blood was then treated with
0.5 mL erythrocyte lysis buffer for 10 min before wash-
ing. Intranuclear staining for bcl-6 was performed as
described [17] using anti-bcl-6-PE (BCL-DWN), eBio-
science. BAL differential cell counts and BAL T cell
cytokine staining were performed as described [16]. A
FACScaliburTM flow cytometer and CellQuest ProTM soft-
ware (BD Biosciences, Oxford, UK) were used. To
identify Tfh in spleen cell populations, an alternative
6-colour protocol was used using a lineage-negative
gating approach and staining for CXCR5, PD-1 and
ICOS to discriminate Tfh. Splenocytes were stained with
fixable near-IR dead cell stain (Life Technologies), then
washed and stained with anti-CD4-FITC, anti-PD-1-
PerCPeFluor710, anti-CXCR5-APC, anti-ICOS/CD278-PE
(C398.4A) and biotinylated antibodies to lineage mark-
ers CD19 (eBio1D3), CD8a (53-6.7), CD11b (M1/70),
CD11c (N418) and FceR1 (MAR-1), all eBioscience. Cells
were washed and stained with streptavidin-BV421 (Bio-
Legend) before analysis on a BD FACS Canto II flow
cytometer. Live cells were gated for CD4+ lineage-nega-
tive cells first, before quantifying CXCR5+PD-1+ICOS+
cells. To assess IgA coating of intestinal microbes [18],
fresh stools were collected from separate cages of
untreated mice of each strain, resuspended in 1 mL PBS
and debris was removed by centrifugation. About 5 lL
supernatant was stained in PBS/FCS with SYBR Green
(Life Technologies, 1/105) and anti-IgA-PE (11-44-2,
eBioscience). Controls contained extracts from wild-
type mice and isotype control antibody. Cells were then
analysed by flow cytometry.
ELISAs
Total IgE was measured by sandwich ELISA as described
[19]. Der p 1-specific IgE was measured by class capture
assay using anti-IgE capture mAb (LOME-3, AbD Serotec,
Kidlington, UK) and detection with biotinylated natural
Der p 1 allergen (Indoor Biotechnologies, Cardiff, UK).
Biotinylation was performed with a Sulfo-NHS Biotinyla-
tion Kit (Thermo Scientific, Loughborough, UK) according
to instructions. Streptavidin–peroxidase (eBioscience)
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was used to reveal binding. Anti-Der p 1 IgGs were mea-
sured by standard ELISA using 1 lg/mL coating with Der
p 1 and detection with anti-mouse IgG isotype-peroxidase
conjugates (AbD Serotec). Antibody tires were expressed
as arbitrary units (AU/mL) by reference to standard curves
of positive control sera. IL-4 and IL-13 in BAL or lymph
node cell supernatants were measured using eBioscience
Ready-Set-GoTM kits according to instructions.
Statistical analysis
GraphPad Prism 5 software (GraphPad, San Diego, CA)
was used to plot and analyse the data. Unpaired t-tests
were used except where significant differences between
variances were observed, in which case Mann–Whitney
tests were employed. Graphs are annotated as
follows: *: P < 0.05, **: P < 0.005, ***: P < 0.0005,
****: P < 0.00005.
Results
CD4Crexgp130/ mice are Tfh-deficient
CD4Crexgp130/ mice have been previously character-
ized in our laboratory and others as Th17-deficient
animals due to their lack of the IL-6R signalling mole-
cule gp130 in the T cell compartment [15, 16]. As it
has recently been demonstrated that IL-6 is also a key
cytokine responsible for development of Tfh cells [12],
we compared CD4Crexgp130/ mice with their wild-
type counterparts for Tfh responses. To avoid the pres-
ence of Th17 cells confounding the interpretation of
the data, we used a model of allergic disease in which
Th17 cells are largely absent, and allergen induces
purely Th2-type responses. In the C57BL/6 strain, this
can be achieved using HDM/alum parenteral sensitiza-
tion followed by HDM intranasal challenge. We used
this protocol in both strains in parallel and detected
Tfh cells by staining for CD4, CXCR5, PD-1 and ICOS
(CD278) [14]. Clearly distinguishable Tfh populations
expressing these markers were only seen in spleno-
cytes after gating out dead cells and cells of lineages
other than CD4 T cells (Figs 1a and b). In peripheral
blood, however, Tfh-like populations were distinguish-
able using a simple 3-colour staining protocol
(Fig. 1c). In both spleen and blood, the frequencies of
Tfh were significantly increased after HDM sensitiza-
tion in wild-type mice (Figs 1b and c). However, there
was no significant increase in these cells in CD4Crexg-
p130/ animals, indicating that they were Tfh-defi-
cient.
To confirm the absence of Tfh cells in CD4Crexg-
p130/ mice, we stained for intranuclear expression of
bcl-6, the signature transcription factor of Tfh [13], and
showed increased bcl-6 staining within CD4 T cells of
HDM-sensitized wild type but not CD4Crexgp130/
mice (Fig. 1d) compared with control animals. To eval-
uate a Tfh-dependent parameter that was not dependent
on allergen sensitization, we assessed the IgA response
to intestinal microbes, which is detectable by flow
cytometry of fecal extracts of untreated mice [18]. The
results (Fig. 1e) show that wild-type mice produce IgA
to these environmental antigens naturally, but
CD4Crexgp130/ animals do not, consistent with their
lack of Tfh cells.
CD4Crexgp130/ mice are deficient in IgG1 and IgE
responses to Der p 1.
Serum from HDM-sensitized animals was assayed for
allergen-specific antibodies (Fig. 2). Only secondary
responses, after the second HDM/alum immunization,
were detected, and peak responses were observed on day
28. Total IgE levels were increased around 40-fold in
HDM-sensitized wild-type animals at this time point, but
this response was reduced by 80–90% in CD4Crexgp130/
 mice. Likewise, both IgE and IgG1 responses to the
major protein allergen of HDM, Der p 1, were dramati-
cally reduced in these animals. Der p 1-specific IgG2a
and IgG3 antibodies, which are associated with Th1-like
responses in mice, were not detectable (not shown).
Allergic airway inflammation in CD4Crexgp130/ mice
is unaltered except in the case of B cell infiltration
Flow cytometry of BAL cells was used to enumerate
leucocyte infiltration of airways on day 28 (Fig. 3a).
This showed highly eosinophilic infiltrates induced by
HDM in both strains, with around 95% of BAL cells
being identified as eosinophils. Very few neutrophils,
associated with Th17 responses, were seen, but these
were significantly reduced in CD4Crexgp130/ mice.
Interestingly, B cells in the BAL, which are not nor-
mally increased in ovalbumin-induced allergic airway
disease in C57BL/6 mice, were dramatically increased in
HDM-sensitized wild-type animals but not in the
CD4Crexgp130/ strain, where this response was
reduced by 75%. To assess general lung inflammation,
lung weights from mice killed on day 28 were com-
pared (Fig. 3b). HDM challenge significantly increased
lung weights in both strains, indicating similar levels of
inflammation. To assess the level of Th2 response in the
lung tissue, cells extracted from lung tissue were
stained for CD4 and IL-33R (ST2), a surface marker
specific for Th2 cells [20]. These results (Fig. 3b)
showed a significant tissue infiltration by Th2-type cells
in HDM-challenged animals, with no difference in
levels of response between strains.
Total T cell numbers in BAL were also increased
similarly in both strains, although there was a
non-significant trend for fewer T cells in BAL of
CD4Crexgp130/ mice (Fig. 3c). To assess T cell
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cytokine profile, BAL T cells were isolated by magnetic
selection, stimulated and intracellular cytokine staining
for IL-4, IL-17 and IFN-c performed in CD4 T cells
(Fig. 3c). The response was highly Th2-skewed, with
large increases in IL-4+ T cells but not IL-17 or IFN-c-
producing cells after HDM challenge. The Th2 response
was not significantly different in CD4Crexgp130/
mice, but they did have significantly fewer Th17 cells
than wild type despite the low numbers. Histological
sections of the lung were examined (Fig. 3d) and
showed inflammation of the airways in both strains of
mice after allergen challenge, with fewer lymphocytes
(T or B cells) being apparent in CD4Crexgp130/, con-
sistent with the BAL cell analysis.
IL-4 and IL-13 production are unaltered in
CD4Crexgp130/ mice
As Tfh cells are reported to be a major source of IL-4
[21], we examined secretion of IL-4 in our HDM model
(Fig. 4). We also measured IL-13, a Th2 cytokine not
produced by Tfh cells [22]. Both cytokines showed the
same pattern, being increased significantly in the BAL
of both strains after HDM challenge. There were also no
Fig. 1. CD4Crexgp130/ mice are deficient in Tfh responses. (a) Staining for CXCR5 and PD-1 on gated lineage-negative, ICOS+ CD4 cells from
spleen of wild-type C57BL/6 or CD4Crexgp130/ mice (gp130/), sensitized and challenged with HDM (day 28) or PBS only. Double-positive
cells were considered Tfh. (b) Pooled data showing proportions of CXCR5+PD-1+ICOS+ CD4 splenocytes from mice as in a; n = 5, one of two inde-
pendent experiments with similar results. (c) Staining for CXCR5 and PD-1 on peripheral blood CD4 T cells of mice as in b. (d) intranuclear stain-
ing for bcl-6 transcription factor in gated splenic CD4+ T cells as in a; representative staining from two experiments is shown. (e) Flow cytometric
detection of IgA coating on bacteria from fecal extracts of untreated wild-type C57BL/6 or CD4Crexgp130/ mice. Samples were stained with
SYBR Green DNA stain to identify bacteria and anti-mouse IgA or isotype control. %IgA-positive cells in DNA+ events is shown; n = 5, one of
two independent experiments with similar results.
Fig. 2. CD4Crexgp130/ mice are deficient in antibody responses to HDM. Animals sensitized as in Fig. 1 were bled on day 14 (primary response)
and day 28 (secondary response) and total or Der p 1-specific IgE or IgG1 were measured as indicated in sera. N = 8–15 mice, pooled from three
independent experiments.
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differences in the secretion of IL-4 and IL-13 in drain-
ing lymph node cells restimulated with HDM in vitro.
These data suggest that Tfh cells were not the major
source of IL-4 or IL-13 in the lung or lymph node.
Discussion
The role of the Th2 cell in allergic diseases such as
asthma was first proposed over 20 years ago [3], and
both intervening and recent data confirm the impor-
tance of this subset in driving allergic disease in
humans [23]. However, the discovery of Tfh cells, which
produce IL-4 but have distinct pathways of differentia-
tion, trafficking and cytokine profile to Th2 cells, has
thrown into question the role of Th2 in IgE synthesis.
Tfh cells are responsible for isotype switching in B cells
and, in a model of helminth infection, were shown to
be the major source of IL-4 [24]. Switching of B cells to
IgG and IgE isotypes occurs primarily at the boundary
of T cell:B cell areas in lymphoid follicles, and
large-scale secretion of these antibodies requires plasma
cell generation in germinal centres [25]. Nevertheless, it
has been suggested that switching to IgE may occur in
other sites, such as mucosal tissues, or in less organized
areas of T cell:B cell interaction than classical germinal
centres [25]. Due to the organization of immunoglobulin
genes, the typical pathway for IgE switching is via an
IgG1 (mice) or IgG4 (human) intermediate stage [10, 11],
and both IL-4 and CD40L are critical in driving the
switching process. However, direct switching from IgM
to IgE synthesis has also been proposed, which might
produce lower affinity IgE antibodies [25]. As Th2 cells
typically express CCR4, CCR3 and CCR8 chemokine
receptors and migrate to inflamed peripheral tissues
such as the lung [26], while Tfh express CXCR5 and
migrate towards germinal centres of lymphoid tissue
[4], we asked whether Tfh were responsible for IgE
switching in HDM-driven allergic disease.
Our results are the first to demonstrate a critical role
for Tfh in IgE responses to an aeroallergen. We first
Fig. 3. CD4Crexgp130/ mice exhibit normal allergic airway inflammation after HDM sensitization and respiratory challenge but lack B cell infil-
tration of the airways. Animals as in Fig. 1 were killed on day 28, and bronchoalveolar lavage cells were enumerated by flow cytometry and left
lungs weighed. N = 9–15 mice, pooled from three independent experiments. (a) cell counts in BAL; (b) left lung weights and proportions of IL-
33R+ cells in CD4 T cells extracted from lung tissue; (c) BAL T cells were isolated and stimulated with anti-CD3/28 magnetic beads and stained
for intracellular cytokines. Total cytokine producing CD4 cells are shown alongside total T cell counts in BAL; (d) haemotoxylin/eosin staining on
histological sections from lungs, showing airways with lymphocytic infiltrates in allergen-challenged mice.
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demonstrated that CD4Crexgp130/ mice are deficient
in Tfh responses, due to the lack of gp130 signalling in
T cells dependent on their lineage-specific genetic
deletion. It should be noted that gp130 is a signalling
component for several cytokine receptors in addition to
IL-6 (the key differentiating factor for Tfh), including
IL-27 and IL-11 [27]. Also IL-6 can induce Th17 as well
as Tfh cells, dependent on the presence of TGF-ß [28].
Therefore, a lack of Tfh cells is not the only immuno-
logical abnormality in CD4Crexgp130/ animals and
this could alter the interpretation of our results. How-
ever, we chose a model with negligible Th17 response
and previous work has shown that these animals are
not immunodeficient, displaying T cell responses that
are generally mildly skewed towards Th2 or regulatory
T cell responses [15, 16]. This contrasts with a recently
described model of Tfh deficiency in which bcl-6 is tar-
geted in T cells [29]. These mice showed deficient Th2-
type responses in lymph node cells after sheep red
blood cell immunization. Thus, although our mouse
model has limitations, it is the most suitable currently
available strain to test our hypothesis.
Our data show a dramatic but not complete defi-
ciency in antibody responses in CD4Crexgp130/mice,
including both IgG and IgE responses. We conclude that
Tfh cells are largely responsible for switching B cells to
IgG1 and IgE in the context of HDM sensitization lead-
ing to release of Der p 1 allergen-specific antibodies.
This conclusion is supported by the facts that (i) the
genetic deficiency in IL-6R was limited to the T cell lin-
eage by expression of the CD4 Cre transgene, excluding
off-target effects of IL-6, (ii) no defect in Th2 responses
was observed in CD4Crexgp130/ animals, as shown
by lung and lymph node responses and previous work
[15, 16], (iii) the ability of CD4Crexgp130/ animals to
produce IgG and IgA antibodies of any isotype or exhi-
bit B cell inflammation was greatly reduced, consistent
with Tfh deficiency. Thus, based on current knowledge
of T cell development, it is reasonable to conclude that
the altered antibody responses were due to a lack of
Tfh cells.
One limitation of our data was the identification of
Tfh cells by flow cytometry using CXCR5 and PD-1
markers. Similar to other reports [30], we found this
population quite difficult to resolve from other T cells
in splenocyte populations and could not reliably iden-
tify them in lymph node cells (not shown). Unexpect-
edly, peripheral blood Tfh cell populations were most
readily detectable. Tfh cells are present in the circula-
tion, although they exhibit distinct characteristics to
the classical Tfh [31, 32]. More definitive Tfh markers
would be useful for cell sorting and adoptive transfer
studies to detail the functions and trafficking of Tfh
populations in allergic models.
Interestingly, allergic airway inflammation was
essentially unaltered in Tfh-deficient mice after HDM
challenge. CD4Crexgp130/ mice are therefore useful
to differentiate the Th2, cell-mediated pathway of aller-
gic disease from humoral and IgE-dependent pathways
which are not essential for eosinophilic inflammation
[33]. IL-6 is essential for Tfh development in vivo by
directing T cell differentiation in cooperation with
IL-21 [12–14]. Tfh-deficient mice had normal levels of
lung inflammation, eosinophilia and Th2 (IL-4-produ-
cing) CD4 T cells in their airways. Although there were
on average fewer Th2 cells in BAL of CD4Crexgp130/
mice, this was not significant and could be explained
by the trend for lower numbers of total T cells in BAL
rather than a shift in cytokine profile, as confirmed by
the IL-33R staining data in lung tissue CD4 cells. The
trend for lower levels of T cell inflammation was also
not significant but might be related to reduced B cell or
neutrophil recruitment in CD4Crexgp130/ mice. As
expected, the genetically altered strain was deficient in
Th17 cells and neutrophils as previously shown in an
ovalbumin model [16]; however, the level of this
response was negligible in comparison to Th2-depen-
dent eosinophilia. Unexpectedly, large numbers of B
cells were seen to infiltrate the airways after HDM chal-
lenge of wild-type mice, a response that is not seen
when using ovalbumin as the allergen which results in
a mixed Th17/Th2 response [16]. This B cell migration
was greatly reduced in Tfh-deficient mice. B cell
Fig. 4. Th2 cytokine levels in lung and lymph node supernatants are
unaltered in CD4Crexgp130/ mice. IL-4 and IL-13 levels were mea-
sured by ELISA in BAL fluid (left) or 4 days supernatants from HDM-
stimulated lymph node cells (LN), from mice as in Fig. 1. N = 8–13
mice, pooled from three independent experiments.
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recruitment is therefore presumably dependent on both
highly polarized Th2 cells in the lung and IgG1/IgE-
switched B cell development. These factors may con-
tribute to local IgE release and mast cell activation. The
IL-4+ CD4 T cells in the airways did not express CXCR5
and are therefore considered Th2 cells (not shown).
Consistent with this, IL-4 and IL-13 levels in the BAL
and secreted from allergen-stimulated lymph node cells
were indistinguishable in Tfh-deficient vs. wild-type
animals. IL-13 is secreted by Th2 cells but not Tfh cells
[22]. These results suggest that in contrast to the
response to helminth infection [24], Th2 cells and not
Tfh are the major source of IL-4 in HDM/alum-driven
sensitization. This was apparent even in draining lymph
node cells where Tfh would be expected to accumulate
in response to allergen.
Our data do not exclude a critical role for Th2 cells
in IgE synthesis. The similar reduction in IgE and IgG1
responses in our model strongly suggests that Tfh cells
are required for IgE switching by providing IgG1-
switched B cells as an intermediate stage [11]. However,
Th2 cells may be involved in later stages of IgE+ B cell
development after Tfh involvement and may also be
responsible for the 10–20% of the IgG1/IgE response
that remained in CD4Crexgp130/ animals. Lastly, they
could be responsible for the recruitment of Tfh-
switched B cells to the airways during inflammation,
driven by HDM exposure. Overall, our data demonstrate
that IL-6-driven Tfh development is a critical stage in
allergic sensitization which may be amenable to thera-
peutic intervention and may help to explain the patchy
response to Th2-targeted therapies [34]. Biotherapeutics
targeting IL-6 are in advanced development for inflam-
matory diseases and might prove useful in long-term
treatment of IgE-mediated pathology.
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